Learn

Knee osteoarthritis (OA) is a progressive, degenerative joint disease that causes pain, stiffness, and decreased range of motion in the knee. It is the most common form of arthritis, affecting about 22% in individuals aged 45 and over. The condition can progress over time and lead to disability, however there are treatments available to help manage the symptoms and improve function.

This education provides the GP with a understanding of how minimally invasive vascular embolization (MIVE) can be a treatment modality to offer instead of, or alongside, more traditional therapies such as pharmacotherapy, physical therapy modalities, intraarticular injections and surgical approaches. In the context of knee OA, MIVE is used to block blood flow to the genicular arteries, which supply blood to the synovial lining of the knee joint, which is often painfully inflamed in knee OA. This can help to reduce inflammation and pain in the knee.

This educational activity will explore what MIVE is, how is is performed, its effects for the patient with knee OA and how to access this novel modality.

Learning Outcomes

1. Describe the role of minimally invasive treatment options for patients with painful knee osteoarthritis who are unsuitable for surgery
2. Outline an approach to patient selection for where minimally invasive vascular embolization can be considered for patients with knee osteoarthritis.

Details

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.

Upon completion, your CPD activity record may take up to 48 hours to be reflected on your CPD Home Dashboard.